T cells - adaptive immunity Flashcards
Hallmarks of adaptive immunity
specifity and diversity
specilisation
non-reactivity to self
clonal expansion
contraction and homeostasis
memory
humoral adaptive immunity
components and function
antibodies produced by B cells
neutralization
phagocytosis
opsonization
complement activation
innate immune system and adptive immune system
interplay
innate IS provides signals to stimulate proliferation and differentiation of adaptive cells to antigen-specific T and B cells
Adaptive cell development
LT-HSC
ST-HSC -> CLP, CMP, MEP
CLP -> T or B cell lineage
T cell commitment dirven by Notch1 and GATA3
B cell commitment by Pax5
driver of proliferation of commited progenitor cells
develop from common lymphoid progenitor
proliferate in response to cytokines
later through signals generated by pre-Ag receptor -> selection of cells with successfully rearranged set of receptor genes
T cell development until committment
from HSC and CLP development of TSC (thymic seeding cell) -> migration from bone marrow to thymus
ETP = DN1 (early thymic progenitor, double negative 1)
DN1: CD44+, develpment to DCs, NK cells, macrophages or DN2a
DN1-checkpoint: commitment when transitioning to DN2a, Notch inhibits alternative fate, start of RAG expression
T cell development of committed progenitors
commitment in DN1 to DN2a transition (DN1 checkpoint -> RAG expression start)
DN2 = CD44+ and CD25+
DN2b -> start of beta-chain rearrangement of TCR
DN3a -> continuing beta rearrangement
DN3 = CD25+ (CD44-)
beta selection Checkpoint: for transition form DN3a to DN3b, marks committment to alpha/beta lineage
T cell development of alpha/beta commited cells
alpha/beta committment in passing beta selection checkpoint from DN3a to DN3b (CD25+)
to DN4 (CD44- CD25-)
to DP cells (double positive CD4+ and CD8+) -> alpha chain rearrangement
POSITIVE & NEGATIVE SELECTION CHECKPOINT: establish central tolerance
positive selection in DP cells: cTEC expressing MHC-peptide, DP receive critical survival signals when binding with low-avidity
transition to SP cells (commit to CD4 or CD8)
negative selection in SP cells: mTEC express TRA on MHC (plus TRA transfer to DC) -> recognition leads to deletion
positive selection checkpoint T cells
POSITIVE & NEGATIVE SELECTION CHECKPOINT: establish central tolerance
positive selection in DP cells: cTEC expressing MHC-peptide, DP receive critical survival signals when binding with low-avidity
then transition to SP cells (commit to CD4 or CD8)
negative selection checkpoint T cells
POSITIVE & NEGATIVE SELECTION CHECKPOINT: establish central tolerance
positive selection in DP cells and cTEC
then transition to SP cells (commit to CD4 or CD8)
negative selection in SP cells: mTEC express TRA on MHC (plus TRA transfer to DC) -> recognition leads to deletion
checkpoint 3 in T cell development
POSITIVE & NEGATIVE SELECTION CHECKPOINT: establish central tolerance
positive selection in DP cells: cTEC expressing MHC-peptide, DP receive critical survival signals when binding with low-avidity
transition to SP cells (commit to CD4 or CD8)
negative selection in SP cells: mTEC express TRA on MHC (plus TRA transfer to DC) -> recognition leads to deletion
DN1 surface markers
CD44+ CD25-
=ETP
can develop to NK, DC, macrophages or DN2a
DN1 checkpoint: Transition to DN2a, committment to T cell lineage (notch prevents reversion), induction of RAG proteins
DN1 checkpoint
first checkpoint
marks committment to T cell lineage (notch prevents reversion)
transition from DN1 to DN2a
induction of RAG proteins
first checkpoint T cell development
DN1 checkpoint
marks committment to T cell lineage (notch prevents reversion)
transition from DN1 to DN2a
induction of RAG proteins
second T cell checkpoint
beta-selection checkpoint
for transition form DN3a to DN3b, marks committment to alpha/beta lineage
beta selection checkpoint
second T cell checkpoint
for transition form DN3a to DN3b, marks committment to alpha/beta lineage
TCR rearranegment
TCR composition, what creates variance
alpha and beta chain with VR and CR
beta chains VR has V, D and J segements, alphas only V and J
non-homologous rearrangement of TCR
- somatic recombination (V(D)J)
- addition/deletion of N and P nucleotides
- transcriptional and RNA processing
non homolougos rearranegment of TCR via
non-homologous rearrangement of TCR
- somatic recombination (V(D)J)
- addition/deletion of N and P nucleotides
- transcriptional and RNA processing
DN3 surface markers
CD44- CD25+
DN2 surface markers
CD44+ CD25+
DN4 surface markers
CD44- CD25-
MHC complexes
for Ag binding -> presentation
peptides need to be bound to MHC -> MHC RESTRICTION of T cells (or MHC like receptors)
MHCI: on all nucleated cells, presents endogenous Ag to CD8
MHCII: on professional APC (macrophages, B cells and DC), present exogenous Ag to CD4
TCR complex
TCR: alpha and beta heterodimer
CD3: epsilon + delta or gamma heterodimer, covalent linkage to TCR, 1 ITAM
zeta chains: homodimer, 3 ITAM
CD4/CD8: interact with MHC, required for signalling and strengthen TCR-MHC binding
TCR signalling
TCR and co-receptors cluster in lipid rafts
Ag recognition
phosphorylation of ITAM by Lck
recruitment of Zap-70
over LAt and Grb2 acttivation of PLCg and RAS/MAPK pathway
activation of distant signalling enzymes and TFs -> alterations in gene expression
Lck
kinase phosphorylating ITAMs upon TCR signalling
causes recruitment of Zap-70 (LAT - Gr2b - PLC and ras/mapk)
signals required for T cell activation
TCR-MHC -> activation
CD28-B7 (CD80/CD86) -> survival
cytokines -> differentiation
co-receptors
prevent or eable TCR signalling
CD28 and B7 -> required for T cell maturation
CTLA4 -> inhibition via competition for B7
PD1 -> inhibition via recruitment of phosphotases (ITIMs)
Superantigens: directly bind MHC and TCR, antigen-specifity is not necessary
inhibition mechanism CTLA4
competitive inhibition (B7 binding)
inhibition mechanism PD-1
recruitment of phosphatases (ITIM)
CD62
selectin
P, E and L
CD62P on ECs activated by histamin or thrombin -> binds neutrophils, monocytes or T cells
CD62E on EC sactivated by cytokines -> binds neutrophils, monocytes or T cells
CD62L on immune cells -> binds ECs adhesion molecules
CD62L
selectin
on immune cells -> binds adhesion molecules on ECs
CD62P
selectin
on ECs activated by histamins orthrombin -> recognizes neutrophils, monocytes or T cells
CD62E
selectin
on ECs activated by cytokines -> recognizes neutrophils, monocytes or T cells
integrins
CD11 and CD18
LFA-1: (CD11a) on immune cells bining ICAM1/2 on ECs
Mac-1: (CD11b) on neutrophils, monocytes and DCs binding ICAM1/2 on ECs
CD49 and CD29
VLA-4: (CD49a) on monocytes, naive and effector T cells binding VACM-1 on ECs
a4b7: (CD49b) on immune cells (esp GIT) binding VCAM1 + MadCAM1 on ECs in gut
CD11aCD18
integrin
LFA-1
on immune cells binding ICAM 1/2 on ECs
CD11bCD18
integrin
Mac-1
on monocytes, neutophils and DC binding ICAm 1/2 on ECs
LAF-1
integrin
CD11aCD18
on immune cells binding ICAm 1/2 on ECs
Mac-1
integrin
CD11bCD18
on monocytes, neutrophils and DC binding ICAm 1/2 on ECs
CD49aCD29
integrin
VLA-4
on monocytes, naive and effector T cells
binding VCAM-1 on ECs
CD49bCD29
integrin
a4b7
on immune cells, especially gut
binding VCAM-1 and MadCAM-1 on ECs in GIT
VLA-4
integrin
CD49aCD29b
on monocytes, naive and effector T cells
binding VCAM-1 on ECs
a4b7
integrin
CD49bCD29
on immune cells, especially gut
binding VCAM-1 and MadCAM-1 on ECs in GIT